About GAPP2™ Survey
The GAPP2™ (Global Attitude of Patients and Physicians) survey was developed to explore and communicate the challenges of managing diabetes, providing real-world data on patients and HCPs views on insulin management, as despite the use of insulin therapy, some people with type 2 diabetes continue to encounter challenges associated with maintaining their glycemic control which can increase their risk of severe complications. The survey was conducted in six countries:
, UK and
and focused on two groups:
About type 2 diabetes in Canada
- People with type 2 diabetes who take insulin
- Healthcare professionals who use insulin to treat people with diabetes
, over three million people have diabetes and approximately 90 per cent of people with diabetes have type 2.
Type 2 diabetes is a disease that occurs when the pancreas does not produce enough insulin to meet the body's needs and/or the body is unable to respond properly to the actions of insulin (insulin resistance). Type 2 diabetes is treated with careful attention to diet and exercise and usually also diabetes medications (antihyperglycemic agents) and/or insulin.
To delay or prevent complications of diabetes, Canadians with type 2 diabetes are encouraged to keep their blood glucose as close to their A1C target as possible.
Hypoglycemia occurs when excess insulin in the blood leads to extremely low glycemic levels,
which can cause confusion, disorientation, loss of consciousness, seizures, and potentially death.
Hypoglycemia is caused by insulin dosage errors or incorrect estimations, and/or missed meals, illness, increased physical activity or increased physical activity without a corresponding increase in carbohydrate consumption.
Complications with insulin account for nearly 14 per cent of all emergency hospitalizations for recognized adverse drug events.
Improved management of medications that control blood sugar levels in people with diabetes can help to reduce hospitalizations for adverse drug events.
The signs of a hypoglycemic event include shaking, sweating, weakness or feeling tired, confusion, nervousness, blurred vision, headachy, fast heart rate, hunger, dizziness, numbness and irritable mood.